Global Abortion Clinical Trials Review, H2, 2015 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z2g564/abortion_global)
has announced the addition of the “Abortion
Global Clinical Trials Review, H2, 2015″ report to their
offering.

Our clinical trial report, “Abortion Global Clinical Trials Review, H2,
2015″ provides an overview of Abortion clinical trials scenario. This
report provides top line data relating to the clinical trials on
Abortion. The report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country (G7
& E7), phase, trial status, end points status and sponsor type.

Key Topics Covered:

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment

Benefits of this Report:

• Assists in formulating key business strategies with regards to
  investment
• Helps in identifying prominent locations for conducting clinical
  trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which
  helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by
  country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing
  a comparative scenario of completed and uncompleted (terminated,
  suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global,
  regional and country level

Companies Mentioned:

• Gynuity Health Projects
• Planned Parenthood Federation of America, Inc.
• Pfizer Inc.
• Nora Therapeutics, Inc.
• Merck & Co., Inc.
• Ibis Reproductive Health
• Biogen, Inc.
• Christiana Care Health System
• Chengdu First Pharmaceutical Co., Ltd.
• Abbott Laboratories

For more information visit http://www.researchandmarkets.com/research/z2g564/abortion_global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women’s
Health, Clinical
Trials